Joan‐Carles Arce

2021

A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients.

Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab155

Study questionIs ovarian stimulation with follitropin delta in its individualised fixed-dose regimen at least as efficacious as follitropin alfa in a conventional dosing regimen in Asian population?Summary answerOvarian stimulation with ind…

2021

Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.

Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02271-5

PurposeTo describe the pregnancy and neonatal outcomes using fresh and vitrified/warmed blastocysts obtained from ovarian stimulation with follitropin delta in controlled trials versus follitropin alfa.MethodsThis investigation evaluated th…

article 2020

QUINAGOLIDE VAGINAL RING FOR ENDOMETRIOSIS: RESULTS FROM THE CLINICAL PHASE 1 PROGRAM

·doi:10.1016/j.fertnstert.2020.08.239

review 2020

Use of dopamine agonists to target angiogenesis in women with endometriosis

Human Reproduction ·doi:10.1093/humrep/deaa337

Endometriosis requires medical management during a woman's reproductive years. Most treatments aim to create a hypoestrogenic milieu, but for patients wishing to conceive, drugs that allow normal ovarian function are needed. Targeting angio…